66. Grantz, K., Claudot, P., Kambala, M., Kouyaté, M., Soumah, A., et al., 2019. Factors influencing participation in an Ebola vaccine trial among front-line workers in Guinea. Vaccine, 37(48), pp.7165-7170.
67. Kuhn J., Adachi T., Adhikari NKJ., Arribas JR., Bah IE., et al., 2019. New Filovirus Disease Classification and Nomenclature. Nature Reviews Microbiology.
68. McDiarmid, M. and Crestani, R., 2019. Duty of care and health worker protections in the age of Ebola: lessons from Médecins Sans Frontières. BMJ Global Health, 4(4), p.e001593.
69. Mulangu, S., 2019. 843. The PALM Consortium: A Multicenter, Multioutbreak Randomized Controlled Trial of Ebola Virus Disease Therapeutics. Open Forum Infectious Diseases, 6(Supplement_2), pp.S12-S13.
70. Nsio, J., Kapetshi, J., Makiala, S., Raymond, F., Tshapenda, G., et al., 2019. 2017 Outbreak of Ebola Virus Disease in Northern Democratic Republic of Congo. The Journal of Infectious Diseases.
71. Williams, A., Amand, M., Van den Bergh, R., De Clerck, H., Antierens, A., et al., 2019. Ensuring On-site Ebola Patient Monitoring and Follow-up: Development of a Laboratory Structure Embedded in an Ebola Treatment Center. Disaster Medicine and Public Health Preparedness, 13(5-6), pp.1028-1034.